Center for Translational Research AB establishes a new regulatory company

Center for Translational Research AB (CTR), holding company for CTC Clinical Trial Consultants AB, starts a new regulatory consulting company with focus on pharmaceuticals and medical device. Marie Gårdmark has been assigned as CEO for the new corporation.

The company will be further strengthened with senior regulatory competence within the areas of medical device and chemistry, manufacturing and control (CMC).

Marie Gårdmark has long regulatory experience as Head of Department and Director of Licensing at the Medical Products Agency and has had several regulatory strategic roles within the pharmaceutical industry.

”We are very happy that Marie Gårdmark with so much experience and knowledge has accepted the role as CEO for this new company. The company will constitute a qualified and important actor in the regulatory area and will assist other companies and scientists to navigate in a complex and rapidly changing regulatory landscape”, says Bengt Dahlström, Chairman of the Board, CTR.

Press contacts

Related stories

CTR launches podcast together with SwedenBIO
11 Apr 2022

CTR launches podcast together with SwedenBIO

The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12.

CTR acquires preclinical toxicology company
06 Apr 2021

CTR acquires preclinical toxicology company

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR.